We have observed that CXCL10 secreting CD103+ DC increased in the tumor tissue in an ascending order of nontreated cancer, PDT, FlaB-Vax, and PDT + FlaB-Vax treatments (Figure 3B). This evidence concerns the gene CXCL10 and neoplasm.